Echo IQ (ASX:EIQ)
@EchoIQ_AI
Followers
145
Following
14
Media
15
Statuses
30
Reinventing how we look at structural heart disease to make stronger care management decisions using the power of AI
Joined May 2022
At #EchoAustralia? Don't miss @PlayfordDavid's lecture at 10:30 AM today in Hall 3--and be sure to drop by booth 18 to chat with the Echo IQ and @HydrixLtd teams! @ScaliaGreg @maddiejane25
0
0
0
#CVTransforum with @MedAxiom was a resounding success! Our team had such a pleasure meeting cardiovascular leaders from across the US, discussing AI, and sharing our research.
0
0
0
We had an excellent time at #ESC2023 presenting multiple studies and reconnecting with our colleagues. Pictured left to right: Simon Stewart, Greg Scalia, Julie Humphries, David Playford, and Geoff Strange
0
0
3
Largest study ever performed assessing the mortality association with increasing LV mass from the National Echo Database of Australia, presented @escardio #ESCCongress. New mortality threshold at 88g/m2 for men and 82g/m2 for women. @thecsanz @ASE360 @EchoIQ_AI @ISHBP @EchofirstB
0
7
15
We need to consider structural heart disease prognoses with a critical eye--and new tools, like AI, can help us ask harder questions and get greater decision-support. Thanks and congrats to @PlayfordDavid on his late-breaking science session at #ESCCongress. #ESC2023
0
0
1
Starting NOW in Vilnius! Don't miss this important late-breaking session covering AI and NLP applied to the world's largest echo database linked to mortality! #ESCCongress #ESC2023 @radcliffeCARDIO
@EchoIQ_AI Very excited to be presenting our top line results of the mortality associated with no, mild, moderate and severe mitral regurgitation tomorrow - Late Breaking Science session @escardio meeting in Amsterdam. Come and see the presentation as embargo is lifted @ASE360 @thecsanz
0
1
1
We're on a roll later this week with two sessions at #ESC2023! These wil highlight the clinical and technical advances our team have made in aortic stenosis and mitral regurgitation detection. https://t.co/uwppJmBh6B
medtechdive.com
1
3
3
The European Society of Cardiology's 2023 congress is just days away! Here are a few of the things the Echo IQ team is looking forward to the most. #ESC2023 #LateBreakingScience #aiinhealthcare
0
0
3
This was a tough one--but it's a whopping *66%* of women who were under-diagnosed according to our latest clinical cohort study. Find out more on August 27th with Professor Geoff Strange at #ESC2023. Get all the details at
Bias in healthcare is a hot topic for a good reason: it harms everyone from the patient to the practitioner. Unconscious biases can be exceptionally treacherous. How prevalent do you think the underdiagnosis of women with aortic stenosis was in a recent trial? #ESC2023
0
0
1
@EchoIQ_AI (#ASX: $EIQ) announces significant expansion to EchoSolv #cardiology platform $EIQ COO, Philip Woolff, joins The Market Herald to discuss further ⬇️ Watch the full video interview here: https://t.co/bv5BTRF829
0
3
3
Are patients with severe aortic stenosis being missed? If so, we can be done to consistently change that? Find out at #ESC2023 on August 27th at 14:00 in the Bratislava room!
0
0
0
We're looking forward to two important late-breaking science presentations from our team at #ESC2023 this year! Speaking first will be @PlayfordDavid on "MR-NEDA - Prognosis of mild to severe MR": Friday, 25th August at 2pm Vilnius Lecture Hall. Don't miss it!
0
0
2
Bias in healthcare is a hot topic for a good reason: it harms everyone from the patient to the practitioner. Unconscious biases can be exceptionally treacherous. How prevalent do you think the underdiagnosis of women with aortic stenosis was in a recent trial? #ESC2023
0
0
0
Click below to watch our latest vlog with EchoIQ Ltd COO Philip Woolff on #Vimeo
https://t.co/HPGLdkVkkc $EIQ @EchoIQ_AI #ASX #AI #ausbiz #tradingday
0
2
2
To improve our detection of the AS phenotype, we used an AI system that ignores LVOT measurements and uses the rest of the echo to find those at risk. #echofirst #AI @EchoIQ_AI @ASE360 #esccongress2022 @escardio
2
3
17
And here are the results - The continuous probability output is divided conveniently into three groups corresponding to no AS, moderate and severe phenotypes. Mortality separation is very clear! Next step for @EchoIQ_AI is to complete reg approval and commercial product.
0
1
3
Late breaking science @escardio today - embargo lifted! #AI diagnosis of #aorticstenosis with @EchoIQ_AI. AUCROC 0.98, correctly identified the AS mortality risk phenotypes of severe AS. Will transform @EchofirstB reporting! @evi2prac @thecsanz @ASE360 @BSEcho #tavi #partnership
0
7
20